Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

Furlan, A.; Higashida, R.; Wechsler, L.; Gent, M.; Rowley, H.; Kase, C.; Pessin, M.; Ahuja, A.; Callahan, F.; Clark, W.; Silver, F.; Rivera, F.

doi:10.1001/JAMA.282.21.2003

Public

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Shared by NobleBlocks on Dec 1, 1999 • 12:00 AM UTC

Authors:

Furlan A

Higashida R

Wechsler L

Abstract

Context Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke onset, but many patients present later after stroke onset and alternative treatments are needed.Objective To determine the clinical efficacy and safety of intra-arterial (IA) ...

Discussions